Entering a New Era – Prostate Cancer Immuno-Therapy After the FDA Approval for Sipuleucel-T

QR Code

Entering a New Era – Prostate Cancer Immuno-Therapy After the FDA Approval for Sipuleucel-T

None

Saved in:

Bibliographic Details
Main Author:	Brill, Thomas H.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/24252
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FDA APPROVES NEW HEMOPHILIA DRUG
by: article Editorial
Published: (2025-02-01)

Overview of drugs approved by the FDA in 2022
by: D. V. Kurkin, et al.
Published: (2023-11-01)

FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN
by: article Editorial
Published: (2024-07-01)

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023-07-01)

THE FDA HAS APPROVED A NEW ANTIBIOTIC FOR THE TREATMENT OF UTIS
by: article Editorial
Published: (2025-05-01)

The FDA has approved a new drug for the treatment of leukemia
by: article editorial
Published: (2024-12-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN
by: article Editorial
Published: (2024-05-01)

THE FDA HAS APPROVED A NEW COMBINED MENINGOCOCCAL VACCINE
by: article Editorial
Published: (2025-05-01)

FDA APPROVED A NEW DRUG FOR THE TREATMENT OF ATOPIC DERMATITIS
by: article Editorial
Published: (2024-09-01)

The FDA has approved the first gene therapy for the treatment of Duchennel's muscular dystrophy
by: article Editorial
Published: (2023-08-01)

The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023-05-01)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022-10-01)

THE FDA HAS APPROVED A NEW TREATMENT FOR HEMOPHILIA A OR B
by: Article Editorial
Published: (2024-11-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR DUCHENE MUSCULAR DYSTROPHY
by: article Editorial
Published: (2024-05-01)

THE FDA HAS APPROVED TWO GENE THERAPY DRUGS FOR THE TREATMENT OF SICKLE CELL ANEMIA
by: article Editorial
Published: (2024-02-01)

The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia
by: article Editorial
Published: (2023-11-01)

FDA HAS APPROVED FIRST FCRN-BLOCKER FOR MYASTHENIA GRAVIS
Published: (2025-07-01)

FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS
by: article Editorial
Published: (2024-09-01)

THE FDA HAS APPROVED THE TRIPLE COMBINATION TOPICAL ACNE REMEDY
by: article Editorial
Published: (2023-12-01)

FDA HAS APPROVED THE LIQUID ADHD MEDICATION (NOT A STIMULANT)
by: article Editorial
Published: (2024-07-01)

The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023-05-01)

FDA Has Approved First Drug for Treatment of Congenital Athymia
by: article Editorial
Published: (2021-12-01)

FDA Has Approved Evolocumab for Theatment of Familial Hypercholesterolemia in Children
by: article Editorial
Published: (2021-12-01)

THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES
by: article Editorial
Published: (2024-02-01)

THE FDA HAS APPROVED THE FIRST VACCINE AGAINST THE CHIKUNGUNYA VIRUS
by: article Editorial
Published: (2023-12-01)

Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer’s Disease
by: Israa J. Hakeem, et al.
Published: (2025-05-01)

FDA HAS APPROVED THE FIRST MEDICATION FOR RARE IMMUNITY-RELATED DISEASES
by: article Editorial
Published: (2024-07-01)

FDA HAS APPROVED NEW TREATMENT FOR CHILDREN WITH ANY HEPATITIS C VIRUS STRAINS
Published: (2020-04-01)

The FDA has approved a new drug for adolescents and adults with severe focal alopecia
by: article Editorial
Published: (2023-08-01)

FDA Has Approved First Long-Acting Growth Hormone Preparation for Children
by: article Editorial
Published: (2021-12-01)

THE FDA HAS APPROVED THE THE FIRST DRUG FOR THE CONGENITAL FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA
by: article Editorial
Published: (2023-12-01)

The FDA has approved the first medical drug for the treatment of primary immunodeficiency APDS
by: article Editorial
Published: (2023-05-01)

Novel Strategies for Discovery, Validation and FDA Approval of Biomarkers for Acute and Chronic Brain Injury
by: Mondello, S., et al.
Published: (2012)

THE FDA HAS APPROVED A DRUG AGAINST NIEMANN–PICK DISEASE, TYPE C
by: Article Editorial
Published: (2024-11-01)

FOR THE FIRST TIME, THE FDA HAS APPROVED A GEL FOR THE TREATMENT OF MOLLUSCUM CONTAGIOSUM AT HOME
by: article Editorial
Published: (2024-02-01)

THE FDA HAS APPROVED THE FIRST DRUG FOR PEOPLE WITH PRADER – WILLI SYNDROME IN MEMORY OF A COLLEAGUE
by: article Editorial
Published: (2025-05-01)

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)
by: Hassan Aliashrafzadeh, et al.
Published: (2025-07-01)

A Comprehensive Overview of US-FDA-Approved Anticancer Drugs and Biologics in 2023: An Observational Study
by: Ajay Kumar Shukla, et al.
Published: (2025-01-01)

Repurposing FDA-approved drugs to find a novel inhibitor of alpha-ketoglutarate-dependent dioxygenase FTO to treat esophageal cancer
by: Zeinab Mohammadi, et al.
Published: (2025-05-01)

Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents
by: Ute Hennrich, et al.
Published: (2025-06-01)